The Biotech Business Handbook: How to Organize and Operate a Biotechnology Business, Including the Most Promising Applications for the 1990s
One comment often repeated to me by coworkers in the biotechnology industry deals with their frustration at not understanding how their particular roles fit into their company's overall scheme for developing, manufacturing, and marketing biomedical products. Although these workers know their fields of specialty and responsibilities very well, whether it be in product research and development, regulatory affairs, manufacturing, packaging, quality control, or marketing and sales, they for the most part lack an understanding of precisely how their own contributory pieces fit into the overall scheme of the corporate biotechnology puzzle. The Biotech Business Handbook was written to assist the biotechnologist-whether a tech nician, senior scientist, manager, marketing representative, or college student interested in entering the field-in building a practical knowledge base of the rapidly expanding and maturing biotechnology segment of the healthcare industry. Because biotechnology in the United States and abroad covers many disciplines, much of the information presented in this book deals with the biomedical diagnostic aspects of the industry. Business subjects for the most part unfamiliar to technically oriented people, such as the types of biotechnology corpo rations, their business and corporate structures, their financing, patent, and trademark mat ters, their special legal issues, and the contributions of their consultants are treated in a manner designed to make them clear and understandable.
What people are saying - Write a review
We haven't found any reviews in the usual places.
Groomed for the
Rapid Test Kits
Tools Used in Recombinant Protein Development
Formal Project Development
Medical Device Export
Other editions - View all
allograft animals antigen antisense application approval assay bacteria biological biomedical bioremediation biotech biotechnology companies biotechnology firms cancer cells chemicals chromosome clinical Community College components containing corporate detection diagnostic disease drug employee Environmental enzyme equipment example factors federal funds gene therapy genetically engineered Health Human Genome Human Genome Project hybridization hybridoma immunoassays infections labeled laboratory manufacturing materials medical devices ment methods microorganisms microparticles molecular molecules monoclonal antibodies mRNA National Institute nology nucleic acid nucleic acid probe oligonucleotides organisms packaging pany patent pathogens performed personnel pharmaceutical phase plasmids polymerase polymerase chain reaction potential probe procedures protein quality control reaction reagents recombinant regulations require research and development restriction enzymes safety SBIR Science scientific scientists sequence Southern blot specific specimen Table target tion tissue toxic transgenic University vaccines viral virus viruses vitro York